← Back to Search

Other

Halneuron for Neuropathy

Fountain Valley, CA
Phase 2
Recruiting
Research Sponsored by Dogwood Therapeutics Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Neuropathic pain has been present and is attributed to platinum and/or taxane chemotherapy.
* Patient has received a cancer chemotherapy regimen that included taxanes and/or platinum and has no active or discernible disease progression.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment to end of study at week 4

Summary

This trial will test if a single injection under the skin of a medication called HAL is safe and effective for treating patients with CINP.

See full description
Who is the study for?
This trial is for adults over 18 who have neuropathic pain due to chemotherapy with taxanes or platinum, and whose cancer isn't currently getting worse. It's not suitable for those who don't meet these specific conditions.Check my eligibility
What is being tested?
The study tests Halneuron against a placebo in managing chemotherapy-induced neuropathic pain. Participants are randomly assigned to receive either the real drug or a placebo via a single subcutaneous injection.See study design
What are the potential side effects?
While the side effects of Halneuron aren't detailed here, typical reactions may include irritation at the injection site, potential allergic reactions, and other systemic responses depending on how it affects the body.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have nerve pain from chemotherapy with platinum or taxane.
 show original
Select...
I've had chemotherapy with taxanes or platinum and my cancer hasn't gotten worse.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment to end of study at week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment to end of study at week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To explore the Safety of Halneuron in the treatment of patients with Chemotherapy-Induced Neuropathic Pain
To explore the efficacy of Halneuron in the treatment of patients with Chemotherapy-Induced Neuropathic Pain
Secondary study objectives
Determine benefits of Halneuron treatment on non-pain outcomes including sleep quality, fatigue and mood
Responder analyses for patient global impression of change (PGIC)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: HalneuronExperimental Treatment1 Intervention
Halneuron
Group II: PlaceboPlacebo Group1 Intervention
Placebo

Find a Location

Closest Location:Profound Research at OMG Division of Clinical Hematology and Medical Oncology· Farmington, MI· 175 miles
Image of Profound Research at OMG Division of Clinical Hematology and Medical Oncology in Farmington, United States.Image of Profound Research at OMG Division of Clinical Hematology and Medical Oncology in Farmington, United States.Image of Profound Research at OMG Division of Clinical Hematology and Medical Oncology in Farmington, United States.

Who is running the clinical trial?

Dogwood Therapeutics Inc.Lead Sponsor
~133 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top